Glenmede Investment Management
SRTA icon

Glenmede Investment Management’s Strata Critical Medical Inc SRTA Stock Holding History

Glenmede Investment Management’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,963
Closed -$20K – 1491
2025
Q2 		$20K Buy
+4,963
New +$16.2K ﹤0.01% 1422

Other funds holding SRTA

ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Third Point
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Glenmede Investment Management's SRTA Position: Q3 2025 in Review

Glenmede Investment Management sold out of Strata Critical Medical Inc (SRTA) in Q3 2025, closing a stake of 4,963 shares — an estimated $20K sold.

Glenmede Investment Management first reported a position in SRTA in Q2 2025 and held it in 1 quarter. The position peaked at $20K in Q2 2025. 137 funds tracked by Wall St. Rank hold SRTA as of Q3 2025.

  • Glenmede Investment Management reported no remaining Strata Critical Medical Inc position as of Q3 2025 after selling out during the quarter.
  • Glenmede Investment Management sold 4,963 Strata Critical Medical Inc shares in Q3 2025, an estimated $20K.
  • Glenmede Investment Management first reported a position in Strata Critical Medical Inc in Q2 2025 and held it in 1 quarter.
  • Glenmede Investment Management's Strata Critical Medical Inc position peaked at $20K in Q2 2025.
  • 137 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.